Predictors of surveillance mammography outcomes in women with a personal history of breast cancer

Breast Cancer Research and Treatment
Kathryn P LowryJanie M Lee

Abstract

To identify predictors of poor mammography surveillance outcomes based on clinico-pathologic features. This study was HIPAA compliant and IRB approved. We performed an electronic medical record review for a cohort of women with American Joint Committee on Cancer (AJCC) Stage I or II invasive breast cancer treated with breast conservation therapy who developed subsequent in-breast treatment recurrence (IBTR) or contralateral breast cancer (CBC). Poor surveillance outcome was defined as second breast cancer not detected by surveillance mammography, including interval cancers (diagnosed within 365 days of surveillance mammogram with negative results) and clinically detected cancers (diagnosed without a surveillance mammogram in the preceding 365 days). Univariate and multivariate logistic regression were performed to identify predictors of poor mammography surveillance outcome, including patient and primary tumor characteristics, breast density, mode of primary tumor detection, and time to second cancer diagnosis. 164 women met inclusion criteria (65 with IBTR, 99 with CBC); 124 had screen-detected second cancers. On univariate analysis, poor surveillance outcome (n = 40) was associated with age at primary cancer diagnosis < 50 ye...Continue Reading

References

Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Apr 8, 2004·Journal of the National Cancer Institute·Sandra M SwainNorman Wolmark
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G ArpinoC K Osborne
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suparna Bonthala Wedam, Sandra M Swain
Feb 21, 2009·The New England Journal of Medicine·Christos Sotiriou, Lajos Pusztai
Mar 20, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N HoussamiS W Duffy
Jul 25, 2009·Breast Cancer Research and Treatment·Monica BrownMary Pare
Oct 1, 2010·Annals of Surgical Oncology·Kay Washington
Feb 24, 2011·JAMA : the Journal of the American Medical Association·Nehmat HoussamiLes Irwig
Jun 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Sep 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nils D ArvoldJay R Harris
Apr 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lowell E SchnipperDana S Wollins
Sep 11, 2012·Journal of Cancer Research and Clinical Oncology·A CaldarellaE Paci
Nov 7, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James L KhatcheressianUNKNOWN American Society of Clinical Oncology
Mar 21, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Nehmat HoussamiDiana L Miglioretti
Jan 11, 2014·Breast Cancer Research and Treatment·Heidi S WirtzDiana S M Buist
Apr 24, 2015·Journal of the National Cancer Institute·Janie M LeeRebecca A Hubbard
May 6, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A S CoatesUNKNOWN Panel Members
Dec 9, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carolyn D RunowiczPatricia A Ganz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Nehmat HoussamiDiana L Miglioretti
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Budhi Singh YadavRakesh K Kapoor
© 2022 Meta ULC. All rights reserved